We want to alert you to a recall of Novartis® and Sandoz® blister packs, effective July 5, 2018. We recommend you review your patients' medical records and contact all patients for whom you have prescribed these medications to warn them of the possible problem.
Novartis and Sandoz Inc. voluntarily recalled the medications after discovering that certain blister-card packages distributed in the U.S. do not meet U.S. child-resistant packaging requirements and are not compliant for consumer home use.
This recall is due to the in-home dispensing of some hospital-unit-dose blister packs intended for institutional use. As a result, Novartis and Sandoz have implemented a corrective action plan at the consumer level for packaging that does not meet U.S. child-resistant packaging requirements. The packaging is not child-resistant, posing a risk of harm if the tablets are swallowed by children.
Recalled Novartis prescription drugs
The recalled Novartis prescription blister packages have “Novartis,” the name of the drug, dosage, National Drug Code (NDC), lot number and expiration date printed on the carton and the blister cards. The recall includes the following: